D-1115-2017 Class II Terminated

Recalled by C. O. Truxton — Bellmawr, NJ

FDA drug recall D-1115-2017 was initiated by C. O. Truxton on April 20, 2017 and is designated Class II. Reason for recall: Labeling: Label Mixup; potentially mislabeled The recall status is terminated (terminated September 11, 2018). Affected quantity: unknown.

Recall Details

Product Type
Drugs
Report Date
August 30, 2017
Initiation Date
April 20, 2017
Termination Date
September 11, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
unknown

Product Description

Amitriptyline HCL Tablets, USP 50 mg, 100 count bottles, Rx Only, Manufactured for: Qualitest Pharmaceuticals Huntsville, AL 35811, Distributed by: Truxton, Inc. Bellmawr, NJ 08031, NDC: 0463-6352-10

Reason for Recall

Labeling: Label Mixup; potentially mislabeled

Distribution Pattern

Nationwide

Code Information

Lot # C0260416A; Exp. 03/18